Cysteamine bitartrate
Cysteamine bitartrate Basic information
- Product Name:
- Cysteamine bitartrate
- Synonyms:
-
- (mercaptoethyl)ammonium hydrogen tartrate
- Cysteamine bitartrate
- Cystagon
- CYSTEAMINE BITRATRATE
- 2-Aminoethanethiol (2R,3R)-2,3-dihydroxysuccinate
- Mercaptamine bitartrate
- CAS:
- 27761-19-9
- MF:
- C6H13NO6S
- MW:
- 227.23
- EINECS:
- 248-641-7
- Mol File:
- 27761-19-9.mol
Cysteamine bitartrate Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO: 45 mg/mL (198.03 mM);Ethanol: Insoluble
- Water Solubility
- Water: 45 mg/mL (198.03 mM)
- InChI
- InChI=1/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/s3
- InChIKey
- NSKJTUFFDRENDM-RZHFEHKBNA-N
- SMILES
- C(N)CS.[C@H](O)(C(=O)O)[C@@H](O)C(=O)O |&1:4,9,r|
Cysteamine bitartrate Usage And Synthesis
Description
Cysteamine bitartrate is an amino thiol and a byproduct of the cysteine degradation pathway that is an FDA-approved therapy for the treatment of nephropathic cystinosis to decrease the accumulation of lysosomal cystine (the disulfide-linked form of cysteine) by engaging in disulfide exchange. In addition, cysteamine bitartrate has been postulated to have broader antioxidant properties potentially related to a distinct role in increasing cysteine availability to support the biosynthesis of the potent antioxidant molecule glutathione[1].
References
[1] Sujay Guha. “Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.” Human molecular genetics (2019): 1837–1852.
Uses
Cysteamine bitartrate (CAS# 27761-19-9) treatment of cystinosis and other metabolic and neurodegenerative diseases.
Cysteamine bitartrateSupplier
- Tel
- 025-66042949 15161141411
- 2244332520@qq.com
- Tel
- 0571-82693216
- info@yuhaochemical.com
- Tel
- 027-87465837 19945049750
- sales@finetechnology-ind.com
- Tel
- 400-6087598 15021221957
- order@canspecsci.com
- Tel
- 0571-82693216
- info@yuhaochemical.com